Kiernan T. DeAngelis
Technik-/Wissenschafts-/F&E-Leiter bei Humacyte Global, Inc.
Aktive Positionen von Kiernan T. DeAngelis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - |
Karriereverlauf von Kiernan T. DeAngelis
Ehemalige bekannte Positionen von Kiernan T. DeAngelis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HUMACYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 | 01.10.2021 |
| ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 | 01.09.2019 |
| UNITED THERAPEUTICS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2013 | 01.05.2017 |
Ausbildung von Kiernan T. DeAngelis
| Brody School of Medicine | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Kiernan T. DeAngelis
- Erfahrung
